Together, the organizations will strengthen revenue cycle operations as Sauk Prairie Healthcare leverages Jorie AI's intelligent automation framework. PRAIRIE DU SAC, WISCONSIN / ACCESS Newswire / ...

Senior professionals in the life sciences must approach networking with strategic intention; not simply exchanging business ...

Automated intake captures accurate patient messages, streamlines clinical tasks, and helps practices regain valuable staff ...

The best rhinoplasty in Seattle is by Dr. Sajan SEATTLE, WA / ACCESS Newswire / November 20, 2025 / In Seattle's growing ...

First-of-its-kind AI-powered chronic care management platform moves clinically proven tools outside the doctor's office ARLINGTON, VA / ACCESS Newswire / November 20, 2025 / FriskaAi, an innovative ...

KENNESAW, GA / ACCESS Newswire / November 20, 2025 / When many people hear the term artificial intelligence, their guard goes up, questions are raised about confidentiality, integrity, and a ...

CEO's personal open-market investment reflects long-term alignment with shareholders and continued commitment to transparency, excellence and innovation. MESA, ARIZONA / ACCESS Newswire / November 20, ...

GOTHENBURG, SE / ACCESS Newswire / November 20, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for Parkinson's disease, today announces that ...

Crofelemer can potentially extend lives of MVID patients - infants and children who face the lethal natural history of the diseaseParenteral support reduction of up to 37% is groundbreaking; No ...

University of Louisville Health pilots tool to tackle capacity constraints and improve patient flow across its system PITTSBURGH, PA / ACCESS Newswire / November 20, 2025 / TeleTracking Technologies, ...

With elite training in endometriosis excision and a commitment to whole-body, multidisciplinary care, Dr. Chu expands ESSE's mission of integrative, patient-centered treatment for complex gynecologic ...

SAN DIEGO, CA / ACCESS Newswire / November 20, 2025 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on rebalancing ...